Doherty G M, Doppman J L, Miller D L, Gee M S, Marx S J, Spiegel A M, Aurbach G D, Pass H I, Brennan M F, Norton J A
Surgical Metabolism Section, National Cancer Institute/NIH, Bethesda, MD 20892.
Ann Surg. 1992 Feb;215(2):101-6. doi: 10.1097/00000658-199202000-00002.
Persistent primary hyperparathyroidism due to mediastinal parathyroid adenoma was effectively treated by either angiographic ablation or median sternotomy in this study of 49 patients managed at the National Institutes of Health since 1977. Each patient presented here with symptomatic persistent primary hyperparathyroidism after failed initial surgical procedures done at other institutions. Each patient underwent extensive parathyroid localization procedures, including selective angiography, and most had a parathyroid adenoma localized to the mediastinum. Angiographic ablation, the deliberate injection of large doses of contrast material into the artery that selectively perfuses the adenoma, was initially successful in 22 of 30 procedures (73%) in 27 patients. Long-term control of persistent primary hyperparathyroidism was achieved in 17 of 27 patients (63%) by angiographic ablation. Each unsuccessful ablation could be easily salvaged by surgical resection. Surgical resection of the parathyroid adenoma by median sternotomy achieved immediate success in 24 of 24 procedures (p2 less than 0.02 versus ablation), and long-term cure in 23 of 23 evaluable patients (p2 less than 0.001 versus ablation). However, ablation did have benefits for the patients in whom it was successfully performed. It was associated with a significantly shorter hospital stay (median, 6 days versus 9 days for sternotomy, p2 less than 0.003), much less pain, and easier recuperation. Complications of each procedure were transient and similar in both groups. Operative resection is the most effective single means to eradicate mediastinal parathyroid adenoma; however, angiographic ablation can provide similar long-term control of hyperparathyroidism in 63% of patients with less pain and shorter convalescence than that seen in patients after median sternotomy. Our results suggest that angiographic ablation should be attempted as the initial procedure for patients with persistent primary hyperparathyroidism caused by an angiographically identified mediastinal parathyroid adenoma. Operation can be reserved for those who fail ablation.
自1977年以来,在国立卫生研究院接受治疗的49例患者的这项研究中,因纵隔甲状旁腺腺瘤导致的持续性原发性甲状旁腺功能亢进通过血管造影消融或正中胸骨切开术得到了有效治疗。这里的每位患者在其他机构进行的初次手术失败后,均表现为有症状的持续性原发性甲状旁腺功能亢进。每位患者都接受了广泛的甲状旁腺定位检查,包括选择性血管造影,大多数患者的甲状旁腺腺瘤定位于纵隔。血管造影消融,即将大剂量造影剂故意注入选择性灌注腺瘤的动脉,在27例患者的30次操作中有22次(73%)最初成功。27例患者中有17例(63%)通过血管造影消融实现了持续性原发性甲状旁腺功能亢进的长期控制。每次消融失败后都可通过手术切除轻松挽救。通过正中胸骨切开术对甲状旁腺腺瘤进行手术切除在24次操作中有24次立即成功(与消融相比,p2小于0.02),在23例可评估患者中有23例实现长期治愈(与消融相比,p2小于0.001)。然而,消融对于成功进行消融的患者确实有好处。它与显著缩短的住院时间相关(中位数,6天,而胸骨切开术为9天,p2小于0.003),疼痛少得多,恢复也更容易。两组中每种手术的并发症都是短暂的且相似。手术切除是根除纵隔甲状旁腺腺瘤最有效的单一方法;然而,血管造影消融可以为63%的患者提供类似的甲状旁腺功能亢进长期控制,且疼痛比正中胸骨切开术后的患者轻,康复时间更短。我们的结果表明,对于由血管造影确定的纵隔甲状旁腺腺瘤引起的持续性原发性甲状旁腺功能亢进患者,应尝试将血管造影消融作为初始治疗方法。手术可保留给消融失败的患者。